Jared Kelly
Chief Executive Officer at Oncolytics Biotech Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 8 months
- Director since
- 2026
8 months of board service in total across 1 board, counting each seat separately. Longest: Oncolytics Biotech Inc., 8 months.
Oncolytics Biotech Inc.
Director · Chief Executive Officer
Chief executive roles
Oncolytics Biotech Inc.
· Chief Executive Officer
Since January 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +5,050 | $0.96 | $4,848 |
| Feb 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +29,500 | $0.84 | $24,780 |
| Feb 11, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +5,600 | $0.84 | $4,704 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.